Participating in research is one of the most powerful things you can do to be part of tomorrow's healthcare breakthroughs. Penn State Health is always looking for people who are willing to participate in studies, so that our researchers can better understand how to diagnose, treat, and prevent diseases and conditions.
Hidradenitis Suppurativa (HS): Assigned to PTM-001 (400mg) or placebo (no active ingredients) for 12 weeks after which all patients will receive the actual study medication, PTM-001 400mg daily for an ...
SLE/CLE Lupus: 18 years and older; SC (subcutaneous injection) every 4 weeks with an additional dose given at Week 2 and Week 26. Randomization is 2:1 BIIB059 to placebo (non ...
Atopic Dermatitis: Open Label, 64 weeks study. Injectable medicine. Males/Females 2-11 years with moderate to severe atopic dermatitis. The goal of the study is assess the uptake of the drug ...
Hidradenitis Suppurativa: Phase 2 Double-Blinded to Open-Label Study, up to 60 weeks long. Oral medication, Males/Females 18-75 years old with Hidradenitis Suppurativa (HS) for at least 3 months Hidradenitis Suppurativa ...
Hidradenitis Suppurativa: Phase 2 Double-Blinded to Open-Label Study, up to 60 weeks long. Oral medication, Males/Females 18-75 years old with Hidradenitis Suppurativa (HS) for at least 3 months Hidradenitis Suppurativa ...
Hidradenitis Suppurativa: Phase 2a Double-Blinded Study, 26 weeks long. Injection under the skin, Males/Females 18-75 years old with Hidradenitis Suppurativa (HS) Hidradenitis Suppurativa (HS), is a recurrent inflammatory skin condition ...
Hidradenitis Suppurativa (HS) is a reoccurring, inflammatory skin condition. HS is known for lesions most commonly found in the groin, armpits, and buttocks. These lesions are very painful and can ...
Hidradenitis Suppurativa (HS) is a reoccurring, inflammatory skin condition. HS is known for lesions most commonly found in the groin, armpits, and buttocks. These lesions are very painful and can ...
Prurigo Nodularis: Phase 2b/3 Subject and Investigator Blinded, 56 Week study. Oral medication taken twice daily, Males/Females 18 years and older with Prurigo Nodularis Prurigo Nodularis (PN) is a skin ...
Prurigo Nodularis: Phase 2b/3 Subject and Investigator Blinded, 56 Week study. Oral medication taken twice daily, Males/Females 18 years and older with Prurigo Nodularis Prurigo Nodularis (PN) is a skin ...
